Evoke Pharma Inc
EVOK
Revenue
2.55M
▲815.88k▲47.01%
3 Months ChangeAssets
12.14M
▼-317.75k▼-2.55%
3 Months ChangeLiabilities
9.47M
▲514.46k▲5.74%
3 Months ChangeFree Cash Flow
0.00
0.000.00%
-Revenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-28
Form 8-K
ID: 0000950170-24-117576
2024-10-22
Form 8-K
ID: 0000950170-24-116111
2024-10-17
Form 8-K
ID: 0000950170-24-115308
2024-09-27
Form 8-K
ID: 0000950170-24-110083
2024-08-16
Form 8-K
ID: 0000950170-24-097805
2024-08-13
Form 8-K
ID: 0000950170-24-095778
2024-08-13
Form 10-Q
ID: 0000950170-24-095776
2024-08-01
Form 8-K
ID: 0000950170-24-088937
2024-06-20
Form 8-K
ID: 0000950170-24-075296
2024-06-07
Form 8-K
ID: 0000950170-24-070217